Reports for APOTEX INC

Company Name

APOTEX INC

Totals

Shortage reports

3038

Actual shortage: 231 (8%)
Anticipated shortage: 14 (0%)
Avoided shortage: 9 (0%)
Resolved: 2784 (92%)

Discontinuation Reports

356

To be discontinued: 22 (6%)
Discontinued: 334 (94%)
Reversed: 0 (0%)

Late reports

142 (4%)

Overdue reports

31 (12%)

Shortage reports
Brand name Strength Dosage Status Date Created Date Updated Reports
APO-METHYLPHENIDATE ER 18MG TABLET (EXTENDED-RELEASE) Resolved 2023-09-07 2023-10-20 203804
APO-METHYLPHENIDATE ER 18MG TABLET (EXTENDED-RELEASE) Resolved 2023-11-06 2024-04-19 209298
APO-VERAP SR 180MG TABLET (EXTENDED-RELEASE) Actual shortage 2017-03-10 2019-12-04 260
APO-DILTIAZ CD 180MG CAPSULE (CONTROLLED-DELIVERY) Resolved 2017-03-10 2018-12-18 284
APO-DILTIAZ CD 180MG CAPSULE (CONTROLLED-DELIVERY) Resolved 2019-02-06 2019-07-12 74872
APO-DILTIAZ CD 180MG CAPSULE (CONTROLLED-DELIVERY) Resolved 2019-03-13 2019-07-12 78484
APO-DILTIAZ CD 180MG CAPSULE (CONTROLLED-DELIVERY) Resolved 2019-08-21 2019-10-15 92022
APO-MYCOPHENOLIC ACID 180MG TABLET (ENTERIC-COATED) Resolved 2019-10-09 2019-11-04 95871
APO-DEFERASIROX (TYPE J) 180MG TABLET Resolved 2020-03-18 2020-03-31 108927
APO-MYCOPHENOLIC ACID 180MG TABLET (ENTERIC-COATED) Resolved 2020-10-07 2021-01-26 125806
APO-DILTIAZ CD 180MG CAPSULE (CONTROLLED-DELIVERY) Resolved 2020-11-19 2020-11-27 128594
APO-DEFERASIROX (TYPE J) 180MG TABLET Resolved 2021-01-08 2021-01-20 131148
APO-DILTIAZ CD 180MG CAPSULE (CONTROLLED-DELIVERY) Resolved 2021-02-26 2021-08-23 134811
APO-MYCOPHENOLIC ACID 180MG TABLET (ENTERIC-COATED) Resolved 2021-06-18 2021-07-26 141247
APO-MYCOPHENOLIC ACID 180MG TABLET (ENTERIC-COATED) Resolved 2022-08-12 2023-01-13 166604
APO-CANDESARTAN 16MG TABLET Resolved 2017-03-11 2017-06-27 639
APO-CANDESARTAN 16MG TABLET Resolved 2018-01-03 2020-02-25 34838
APO-CANDESARTAN 16MG TABLET Resolved 2020-06-24 2021-06-14 118761
APO-CANDESARTAN 16MG TABLET Resolved 2020-06-24 2020-09-21 118763
APO-CANDESARTAN 16MG TABLET Resolved 2021-05-14 2021-07-30 139406

Showing 2041 to 2060 of 3038

Discontinuation reports
Brand name Strength Dosage Status Date Created Date Updated Reports
APO-HYDROMORPHONE CR 6MG CAPSULE (EXTENDED RELEASE) Discontinued 2020-04-04 2020-04-04 110959
APO-BOSENTAN 62.5MG TABLET Discontinued 2019-01-04 2019-01-04 71339
APO-ATOMOXETINE 60MG CAPSULE Discontinued 2018-09-07 2018-09-15 60273
APO-GEMFIBROZIL 600MG TABLET Discontinued 2017-03-31 2017-03-31 4927
APO-CAPTO TAB 6.25MG 6.25MG TABLET Discontinued 2018-09-07 2019-06-12 60339
APO-CARVEDILOL 6.25MG TABLET To be discontinued 2024-01-26 2024-01-26 217499
APO-HALOPERIDOL TAB 5MG 5MG TABLET Discontinued 2017-03-13 2017-03-13 1087
APO-METOCLOP TAB 5MG 5mg tablet Discontinued 2017-03-13 2017-03-13 1105
APO-NITRAZEPAM 5MG TABLET Discontinued 2017-03-13 2018-12-07 1110
APO-TERAZOSIN 5MG TABLET Discontinued 2017-03-30 2018-02-05 4749
APO-BISACODYL 5MG TABLET (DELAYED-RELEASE) Discontinued 2018-09-07 2018-09-15 60288
APO-DONEPEZIL 5MG TABLET Discontinued 2018-09-07 2018-10-12 60450
APO-DONEPEZIL 5MG TABLET Discontinued 2018-09-07 2019-02-13 60453
APO-ENALAPRIL 5MG TABLET Discontinued 2018-09-07 2018-11-02 60468
APO GLYBURIDE TAB 5MG 5MG TABLET Discontinued 2018-09-07 2018-12-14 60518
APO-LISINOPRIL 5MG TABLET Discontinued 2018-09-07 2019-02-13 60585
APO PREDNISONE TAB 5MG 5MG TABLET Discontinued 2018-09-08 2018-12-28 60699
APO-ROSUVASTATIN 5MG TABLET Discontinued 2018-09-08 2018-09-15 60775
APO-ALENDRONATE 5MG TABLET Discontinued 2019-01-03 2019-12-21 71023
BISACODYL 5MG TABLET (DELAYED-RELEASE) Discontinued 2019-01-03 2019-01-03 71090

Showing 21 to 40 of 356